Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201, Unichem Laboratories has informed that ICRA, the credit rating agency has downgraded the long-term rating on the Rs 176 crs bank facilities of the Company to [ICRA] A- (Stable) (pronounced ICRA A minus with a Stable outlook). This rating indicates have adequate degree of safety regarding timely servicing of financial obligations. Such instruments carry low credit risk. The company has enclosed letter dated September 16, 2022, issued by ICRA in this regard.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: